本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akari Therapeutics PLC

1.10
-0.0307-2.72%
成交量:8,044.00
成交额:8,932.95
市值:3,539.40万
市盈率:-0.66
高:1.12
开:1.12
低:1.10
收:1.13
数据加载中...
2019/12/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

SEC问询函

[Cover]Correspondence
2019/10/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/15

招股说明书

Registration statement for certain foreign private issuers
2019/10/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/04

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/06

SEC问询函

[Cover]Correspondence
2019/08/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/30

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/08/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/19

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/06

招股说明书

Registration statement for certain foreign private issuers
2019/07/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]